Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 14,314

Document Document Title
WO/2022/168650A1
Provided are a novel homocysteine derivative and a method for producing the same, a composition comprising the compound, and an anti-inflammatory agent comprising the compound and/or the composition. A compound represented by formula 1.  
WO/2022/169363A1
The invention provides a method for the extraction of an organic acid (10) from a mixture (110), the method comprising: an extraction stage comprising providing the mixture (110) to a sorbent (150); an elution stage comprising passing an...  
WO/2022/166737A1
The present invention belongs to the field of agricultural insecticides and acaricides. In particular, the present invention relates to a biphenyl compound containing sulfide (sulfoxide) substitution and use thereof. The structure is as ...  
WO/2022/166837A1
Disclosed are an aryl sulfide, a synthesis method therefor, and an application thereof. The aryl sulfide is a compound of the structure represented by formula I or an agriculturally acceptable salt thereof. The aryl sulfide and the agric...  
WO/2022/163950A1
The present invention relates to a quantum dot composition, a preparation method therefor, and a cured film, a color filter and a display device which comprise same. Specifically, a solventless quantum dot composition according to the pr...  
WO/2022/155728A1
Provided herein is a compound having a structure of Formula (I): (Formula (I)) wherein: D is S, O or an ester; p is 1 to 6; L1 and/or L2 are independently linear or branched C1-C30 alkyl, optionally having one or more C=C double bonds of...  
WO/2022/156005A1
The present invention relates to the field of fine chemical engineering, and in particular, to a method for preparing an α-acyloxy-thioether derivative. The technical key points are as follows: compound A, carboxylic acid B, a sodium sa...  
WO/2022/152705A1
Compounds of Formula (I) wherein R1, R3, R11, R12, X, Y1, Y2, Y3, Y4 and formula (II) are as defined in the description. Medicaments.  
WO/2022/149461A1
The nonlinear light absorption material according to one mode of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R15 each independently include at least one atom selected...  
WO/2022/144292A1
The invention relates in particular to a process for the preparation of DL/LD-methionine diketopiperazine (I) characterized in that a DD/LL-methionylmethionine-containing aqueous solution or suspension, which has a pH of 3 to 7, measured...  
WO/2022/136641A1
The present invention generally relates to the field of ionizable (also termed cationic) lipids, and in particular provides a novel type of such lipids as represented by formula (I). The present invention further provides methods for mak...  
WO/2022/117951A1
The present invention relates to a method for synthesising functionalised mercaptan, comprising the reaction between a compound of formula R2-X-C*H(NR1R7)-(CH2)n-G (II) and H2S in the presence of at least one enzyme chosen from among the...  
WO/2022/116596A1
The invention relates to a concrete micro-foaming agent. The concrete micro-foaming agent contains the following components in parts by weight: 100-150 parts of a sulfonating agent, 0-100 parts of an alkaline agent, 100-200 parts of a un...  
WO/2022/104137A1
The disclosure provides recording materials including propane derivatized monomers and polymers for use in volume Bragg gratings, including, but not limited to, volume Bragg gratings for holography applications. Several structures are di...  
WO/2022/104113A1
The disclosure provides recording materials including mono- or poly-phenyl-core derivatized monomers and polymers for use in volume Bragg gratings, including, but not limited to, volume Bragg gratings for holography applications. Several...  
WO/2022/090566A1
The present invention relates to the use of specific eugenol derivatives as stabilizers of organic materials against oxidative, thermal and/or actinic degradation. The present invention also relates to stabilized organic material and to ...  
WO/2022/092655A1
Disclosed is a method for preparing a thiomethylphenol derivative, the method comprising steps of: (a) performing a primary reaction of a phenol derivative represented by chemical formula 2, a mercaptan derivative represented by R4SH, an...  
WO/2022/084633A1
The invention relates to a preparation of a compound of formula (I), [Chem 1] CH3XCH2CH2C(NH2)COOH (I) wherein X represents S or Se, by catalytic conversion of a compound of formula (II) [Chem 2] CH3XCH2CH2C(Y)CN (II) wherein X represent...  
WO/2022/084632A1
The invention relates to a method for preparing 2-hydroxy-4-methylthiobutyric acid (HMTBA) or 2-hydroxy-4-methylselenobutanoic acid (HMSeBA) by catalytic conversion of 2-hydroxy-4-methylthiobutyronitrile or of 2-hydroxy-4-methylselenobut...  
WO/2022/082859A1
Provided is a refining method for an amino acid or derivatives thereof, comprising: (1) preparing a saturated aqueous solution of an amino acid or derivatives thereof from a crude product of the amino acid or derivatives thereof at prese...  
WO/2022/079637A1
Analogues of oleuropein and oleacein and pharmaceutically acceptable salts thereof and processes for the preparation of these compounds are disclosed. The invention further relates to use of oleuropein and oleacein analogues for the trea...  
WO/2022/080409A1
The present disclosure pertains to: an ester compound that is a transesterification reactant between a polyol and a dicarboxylic acid ester having a disulfide bond and that has, in a molecule chain, a disulfide bond and has, at a termina...  
WO/2022/078940A1
The present invention relates to D,L-methionine, comprising based on the total weight of the D,L- methionine from 15 to less than 50 wt.-% of the D,L-methionine with a particle size from more than 0 to less 150 micrometer, from 50 to les...  
WO/2015/136292A9
The invention relates to a DDX3X inhibitorfor use in the treatment of pneumovirus infection in a mammal, wherein the DDX3X inhibitor may be a compound of Formula (I) wherein y, Z, R1, X, L, Ra and Rb are as defined herein. The invention ...  
WO/2022/071363A1
Provided is a new production method for a fluorinated organic compound (1) which involves a step A in which, in a liquid composition containing an organic solvent, IF5 is used to fluorinate a hydrogen atom-containing organic compound (2)...  
WO/2022/051804A1
Compounds of Formula (A) and methods for use as agricultural chemicals, including herbicides. Formula (A)  
WO/2022/043435A1
The present invention relates to a compound which can be used in the treatment of infections caused by SARS coronaviruses, e.g. by blocking the active site of the proteases 3CLpro and PLpro. The compound can be used as inhibitor or label...  
WO/2022/043322A1
The present invention relates to compounds of formula (la) and the use thereof as inhibitors of P. aeruginosa virulence factor LasB. Formula (la). These compounds are useful in the treatment of bacterial infections, especially caused by ...  
WO/2022/041739A1
The present invention belongs to the technical field of quaternary ammonium salt compounds, and specifically relates to a degradable quaternary ammonium salt compound. The structural general formula of the quaternary ammonium salt compou...  
WO/2022/038477A1
The object of the invention concerns a quaternary ammonium salt of formula (I) wherein the substituents R5, R6 are independently chosen between hydrogen H and a radical R0, wherein the radical R0 consists of the structure of formula (II)...  
WO/2022/029400A1
The present invention relates to an ectoparasiticide veterinary composition comprising a nutraceutical sourced from Allium sativum comprising at least one compound of the formula (I): wherein n is at least 4 and in which R1 is selected f...  
WO/2022/018352A1
The present invention relates to a method for synthesising functionalised mercaptans, essentially in the absence of oxygen, as well as a composition particularly for implementing said method. The functionalised mercaptans have the follow...  
WO/2022/012483A1
The present invention relates to the field of agricultural acaricides, and in particular to a substituted phenyl sulfide compound and an application thereof. The substituted phenyl sulfide compound is as represented by general formula I....  
WO/2022/014702A1
Provided are a metal-organic framework suitably used as a functional material, and a method for manufacturing same, the metal-organic framework containing a cluster (α) and a cluster (β) as constituent units respectively, wherein the c...  
WO/2022/012036A1
The present invention relates to the technical field of fine chemical industry. Disclosed is a method for preparing asymmetric disulfide. The specific steps comprise: using 3-methylthio-N-phenylpropionamide and diphenyl disulfide as raw ...  
WO/2022/011174A1
Novel compounds and compositions including the same and methods of manufacturing and using the same, particularly for inhibiting HDAC or HDAC activity, and more particularly for enhancing renal recovery following acute kidney injury (AKI...  
WO/2022/008505A1
The present invention relates to a process for preparing 3-methylthiopropionaldehyde, comprising the steps of a) providing a liquid stream (1) comprising methyl mercaptan and/or the hemi thioacetal formed from 3-methylthiopropionaldehyde...  
WO/2021/258154A1
The present invention relates to TLR2 agonist compounds and their compositions, and the use of such compounds and compositions in the prevention and/or treatment of respiratory infections, or diseases or conditions associated with viral ...  
WO/2021/255737A1
The present disclosure pertains to amino cyclohexanone compounds, pharmaceutical compositions containing same and methods of treating depression, pain, inflammation, and other clinical indications.  
WO/2021/255552A1
Provided are amino acid based polymerizable compounds and their applications in ophthalmic devices. The amino acid based polymerizable compounds are of formula I: wherein R, R1, and R2 are as described herein.  
WO/2021/251481A1
Provided is a composition for protective film formation which can form a flat film that satisfactorily functions as a mask (protection) against wet etchants during semiconductor substrate processing and that has a low dry etching rate, t...  
WO/2021/252665A1
Provided herein are compositions suitable for recording holograms containing thiol and/or thioether functionality, and optionally including additional allyl and/or propargyl functional groups. These monomers can be used to synthesize hol...  
WO/2021/246349A1
This method for producing a thiol compound comprises a light irradiation step in which a thiol compound having a color or a composition including said thiol compound is irradiated with light. In the light irradiation step, the compositio...  
WO/2021/241582A1
The present disclosure provides an agent for treating or preventing ophthalmopathy such as presbyopia, the agent containing as an active ingredient a sulfur-containing compound having a prescribed structure.  
WO/2021/241781A1
The present invention relates to a recombinant-phage-based container for a stem cell culture, and a use thereof. More specifically, provided are: a recombinant-phage-based container for a stem cell culture, on which cysteamine and a reco...  
WO/2021/219375A1
An effective process of making Ν,Ν'-diacetyl-L-Cystine ("NDAC"), which process is fast, green, does not require labor-intensive isolation or purification of the product, by yielding products in desired ratio, and has improved yield and...  
WO/2021/221059A1
The present invention provides a method for producing a monosulfoxide derivative.  
WO/2021/219377A1
A process of making Ν,Ν'-diacetyl-L-Cystine disodium salt, the process comprising: (i) Mixing hydroxy alkane (between 0.5-100L, preferably between 0.5-10L, more preferably between 1-3L, most preferably 1 L per mol of cystine) with a so...  
WO/2021/214243A1
The present invention relates to a method for preparing a compound T having a thioether group from a compound D having a disulfide group in the presence of a carbene.  
WO/2021/212220A1
Isolated, pure, soluble isoform free recombinant human interferon alpha 2b (rhIFN α-2b). Methods of making the soluble isoform free rhIFN α-2b. Stable compositions and formulations of isoform free rhIFN α-2b are for administration gen...  

Matches 1 - 50 out of 14,314